Latest News:

ar deelen fr it

TIF

The future of genome editing in Europe – Bringing together the views of government, industry, patient communities, and civil society’ representatives

Genome editing is a breakthrough healthcare technology which has the potential to notably cha...
Rapamycin

Update: 27 September 2019 Rapamycin, a drug widely used for almost 20 years to protect organ ...
Mitapivat (AG-348)

Update: 27 September 2019 DRIVE PK is an ongoing global, open-label, Phase 2, safety and effi...
Delegation visit to Oman – 10-11 September 2019

A TIF Delegation Visit to Oman took place on 10 – 11 September 2019 as a follow up to the 2017...
Delegation visit to Kuwait – 8-9 September 2019

...

Highlights

TIF e-AcademyAcadémie électronique de la FITe-Academyالأكاديمية الإلكترونية للاتحاد الدولي للثلاسيمياΗλεκτρονική ΑκαδημίαTIF e-Akademie

Patients' StoriesRécits de patientsStorie di pazientiقصص المرضىΙστορίες ΑσθενώνErfahrungsberichte von Patienten

Clinical Trial UpdatesEssais cliniques - Mises à jourAggiornamenti sugli studi cliniciآخر مستجدات التجارب الإكلينكية Ενημερώσεις για κλινικές δοκιμέςUpdate zu klinischen Studien

Renzo Galanello FellowshipsBourses Renzo GalanelloBorsa di studio Renzo Galanelloمنحة رينزو جالانيلوΥποτροφίες Renzo GalanelloRenzo Galanello Stipendien

International Thalassaemia DayJournée Mondiale de la ThalassémieGiornata internazionale della talassemiaاليوم العالمي ’للثلاسيميا’Παγκόσμια Ημέρα ΘαλασσαιμίαςInternationaler Tag der Thalassämie

The THALIA ProjectThe THALIA ProjectThe THALIA ProjectThe THALIA ProjectThe THALIA ProjectThe THALIA Project

Supporters Sympathisants Sostenitori الداعمون Οι Υποστηρικτές μας Unterstützer